Presentation

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Patrick W. Serruys

September 21, 2018

REGISTER for free or LOG IN to view this content

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Coronary

Presentation

TCT 2018

DES/BRS/DCB

Up Next

Presentation

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

Presenter: Ulrich Schäfer

September 21, 2018

More slides +

Presentation

TCT-53: Role of Single OCT Morphological Variable in the CLIMA Trial (Relationship between Coronary pLaque morphology of the left anterIor descending artery and long terM clinicAl outcome)

Presenter: Enrico Romagnoli

September 21, 2018

Presentation

TCT-45: Quality of Life Outcomes after Transcatheter Mitral Valve Repair in an Unselected Population. A Report from the STS/ACC TVT RegistryTM

Presenter: Suzanne V. Arnold

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.